SA finalising R25m investment to boost pan-African vaccine manufacturing capabilities

  • 📰 TheCitizen_News
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 75%

Business News News

Business Business Latest News,Business Business Headlines

The SA Medical Research Council and the department of science and innovation have provided R10 million funding for the first South African Covid-19 vaccine trial.

South Africa is in the process of finalising a R25 million investment to boost pan-African Covid-19 vaccine manufacturing capabilities.

“We are currently in the process of finalising a R25 million investment to boost pan-African vaccine manufacturing capabilities through the African Renaissance Fund.” “As the international community, we have been unanimous that services, supplies, products and technologies for prevention, treatment and care of COVID-19 must be available to all. No country must be left behind.”

“One looks for instance at the advances in ventilator development and production in developing countries.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in BUSİNESS

Business Business Latest News, Business Business Headlines